Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After H
The purpose of this study is to allow us to assess the effectiveness (or success) of starting pelvic floor physical therapy (i.e. exercises for your pelvic muscles) prior to HoLEP (holmium laser enucleation of the prostate) surgery for enlarged prostates in order to manage or prevent urinary incontinence (i.e. leaking)
| Condition(s) | Benign Prostatic Hyperplasia With Outflow Obstruction, Urinary Retention, Lower Urinary Tract Symptoms |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The purpose of this study is to allow us to assess the effectiveness (or success) of starting pelvic floor physical therapy (i.e. exercises for your pelvic muscles) prior to HoLEP (holmium laser enucleation of the prostate) surgery for enlarged prostates in order to manage or prevent urinary incontinence (i.e. leaking) after surgery (i.e. post-operatively). Your pelvic floor refers to the muscles under your bladder along your pelvic bones that prevent you from leaking urine or stool. Traditionally, pelvic floor physical therapy is started after surgery and continued until urinary continence (i.e. no leaking of urine) is regained. We want to assess if beginning pelvic floor physical therapy prior to surgery (and continuing afterwards) reduces the time required to regain urinary continence f |
| Who can participate | Inclusion Criteria: 1. Age: \>=18 years of age 2. Sex: male sex assigned at birth (needs to have a prostate) 3. BMI: all BMI 4. Ethnic background: all ethnicities 5. Medical history: patients scheduled to undergo HoLEP for BPH/LUTS and associated complications (i.e. gross hematuria, retention, etc.). Exclusion Criteria: 1. Neurological disorders: patients with a history of a neurologic disorder that could affect muscle function, neurogenic bladder, lumbosacral spine pathology 2. Specific urologic conditions: patients with pre-operative indwelling catheter, urethral stricture greater than 1 centimeter in length or requiring dilation/incision, indwelling ureteral stent 3. History of pelvic radiation: patient with prior pelvic radiation will be excluded 4. Patients unable to give consent 5. N |
| Ages | 18 Years |
| Sex | Male |
| Lead sponsor | The Cleveland Clinic |
| Locations | Cleveland, Ohio, United States |
| Start date | 2023-11-29 |
| NCT ID | NCT06179654 |
| Official listing | https://clinicaltrials.gov/study/NCT06179654 |